VIAV Stock Analysis: Viavi Solutions | NASDAQ
Communication Equipment | NASDAQ, USA | Market Cap: 6.468m USD | 12M Return: 62.3% | US9255501051 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 181M
EPS Trend: 90.3%
Qual. Beats: 8
Rev. Trend: 90.1%
Qual. Beats: 6
Warnings
Tailwinds
Seasonality 11.7 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Viavi Solutions Inc. (NASDAQ: VIAV) is a U.S.-based communications equipment provider headquartered in Chandler, Arizona, that delivers test and measurement and optical technologies to military, aerospace, railway, and first-responder communications markets across the Americas, EMEA, and Asia-Pacific. Founded in 1923 and formerly known as JDS Uniphase Corporation, the company has been public since 1993 and carries a large-cap market capitalization of roughly $10.1 billion. Its diversified revenue base spans two operating segments: Network and Service Enablement (NSE), which offers test, monitoring, assurance, and resilient positioning, navigation, and timing (PNT) solutions for critical infrastructure, along with instruments, software, and lifecycle services; and Optical Security and Performance Products (OSP), which applies proprietary optical coating and high-volume manufacturing capabilities to anti-counterfeiting, 3D sensing, government/aerospace, automotive, and industrial end markets. The dual-segment model blends recurring service and software support revenue with component-level optical sales, positioning Viavi across both telecom infrastructure workflows and broader industrial sensing applications.
- 5G and fiber capex cycle drives NSE test equipment demand
- 3D sensing revenue from consumer electronics anchors OSP segment
- Defense and aerospace optical orders offset telecom cyclicality
| Net Income: 67.0m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.03 > 0.02 and ΔFCF/TA 0.22 > 1.0 |
| NWC/Revenue: 26.54% < 20% (prev 43.03%; Δ -16.49% < -1%) |
| CFO/TA 0.04 > 3% & CFO 113.9m > Net Income 67.0m |
| Net Debt (170.1m) to EBITDA (273.0m): 0.62 < 3 |
| Current Ratio: 1.65 > 1.5 & < 3 |
| Outstanding Shares: last quarter (266.2m) vs 12m ago 19.43% < -2% |
| Gross Margin: 58.94% > 18% (prev 56.65%; Δ 2.29% > 0.5%) |
| Asset Turnover: 72.30% > 50% (prev 55.00%; Δ 17.29% > 0%) |
| Interest Coverage Ratio: 3.27 > 6 (EBIT TTM 164.7m / Interest Expense TTM 50.3m) |
| A: 0.17 (Total Current Assets 1.14b - Total Current Liabilities 687.2m) / Total Assets 2.59b |
| B: -26.92 (Retained Earnings -69.7b / Total Assets 2.59b) |
| C: 0.07 (EBIT TTM 164.7m / Avg Total Assets 2.34b) |
| D: 1.05 (Book Value of Equity 1.32b / Total Liabilities 1.26b) |
| Altman-Z'' = -85.04 = D |
| DSRI: 0.83 (Receivables 335.0m/273.8m, Revenue 1.69b/1.15b) |
| GMI: 0.96 (GM 56.65% / 58.94%) |
| AQI: 1.20 (AQ_t 0.47 / AQ_t-1 0.39) |
| SGI: 1.47 (Revenue 1.69b / 1.15b) |
| TATA: -0.02 (NI 67.0m - CFO 113.9m) / TA 2.59b) |
| Beneish M = -2.75 (Cap -4..+1) = A |
As of November 09, 2026, the stock is trading at USD 28.47 with a total of 13,125,680 shares traded. Over the past week, the price has changed by -4.85%, over one month by -40.86%, over three months by -29.86% and over the past year by +62.31%.
Current recommended Stop Loss: 25.00 (which is 12.2% or 1.2 ATR below the current price).
Viavi Solutions has received a consensus analysts rating of 4.63. Therefore, it is recommended to buy VIAV.
- StrongBuy: 6
- Buy: 1
- Hold: 1
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 62.6 | 119.8% |
P/E Trailing = 101.1539
P/E Forward = 17.6367
P/S = 3.8305
P/B = 4.9881
P/EG = 1.3402
Revenue TTM = 1.69b USD
EBIT TTM = 164.7m USD
EBITDA TTM = 273.0m USD
Long Term Debt = 397.1m USD (from longTermDebt, last fiscal year)
Short Term Debt = 245.1m USD (from shortTermDebt, last quarter)
Debt = 698.9m USD (from shortLongTermDebtTotal, last quarter) + Leases 56.4m
Net Debt = 170.1m USD (calculated: Debt 698.9m - CCE 528.8m)
Enterprise Value = 6.64b USD (6.47b + Debt 698.9m - CCE 528.8m)
Interest Coverage Ratio = 3.27 (Ebit TTM 164.7m / Interest Expense TTM 50.3m)
EV/FCF = 80.17x (Enterprise Value 6.64b / FCF TTM 82.8m)
FCF Yield = 1.25% (FCF TTM 82.8m / Enterprise Value 6.64b)
FCF Margin = 4.90% (FCF TTM 82.8m / Revenue TTM 1.69b)
Net Margin = 3.97% (Net Income TTM 67.0m / Revenue TTM 1.69b)
Gross Margin = 58.94% ((Revenue TTM 1.69b - Cost of Revenue TTM 693.3m) / Revenue TTM)
Gross Margin QoQ = 61.22% (prev 62.49%)
Tobins Q-Ratio = 2.56 (Enterprise Value 6.64b / Total Assets 2.59b)
Interest Expense / Debt = 7.20% (Interest Expense 50.3m / Debt 698.9m)
Taxrate = 38.19% (40.4m / 105.8m)
NOPAT = 101.8m (EBIT 164.7m * (1 - 38.19%))
Current Ratio = 1.65 (Total Current Assets 1.14b / Total Current Liabilities 687.2m)
Debt / Equity = 0.53 (Debt 698.9m / totalStockholderEquity, last quarter 1.32b)
Debt / EBITDA = 0.62 (Net Debt 170.1m / EBITDA 273.0m)
Debt / FCF = 2.05 (Net Debt 170.1m / FCF TTM 82.8m)
Total Stockholder Equity = 1.11b (last 4 quarters mean from totalStockholderEquity)
RoA = 2.87% (Net Income 67.0m / Total Assets 2.59b)
RoE = 6.02% (Net Income TTM 67.0m / Total Stockholder Equity 1.11b)
RoCE = 10.90% (EBIT 164.7m / Capital Employed (Equity 1.11b + L.T.Debt 397.1m))
RoIC = 4.94% (NOPAT 101.8m / Invested Capital 2.06b)
WACC = 11.66% (E(6.47b)/V(7.17b) * Re(12.44%) + D(698.9m)/V(7.17b) * Rd(7.20%) * (1-Tc(0.38)))
Discount Rate = 12.44% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: 69.53 | Cagr: 8.21%
[DCF] Terminal Value 68.04% ; FCFF base≈74.5m ; Y1≈85.4m ; Y5≈125.7m
[DCF] Fair Price = 4.15 (EV 1.19b - Net Debt 170.1m = Equity 1.02b / Shares 245.9m; r=11.66% [WACC]; 5y FCF grow 15.0% → 2.50% )
EPS Correlation: 90.29 | EPS CAGR: 55.70% | SUE: 4.0 | # QB: 8
Revenue Correlation: 90.11 | Revenue CAGR: 19.94% | SUE: 2.92 | # QB: 6
EPS current Quarter (2026-12-31): EPS=0.40 | Chg30d=+1.10% | Revisions=+67% | Analysts=7
EPS next Quarter (2027-03-31): EPS=0.40 | Chg30d=-0.47% | Revisions=+67% | Analysts=7
EPS current Year (2027-06-30): EPS=1.64 | Chg30d=+0.07% | Revisions=+0% | GrowthEPS=+64.4% | GrowthRev=+24.3%
EPS next Year (2028-06-30): EPS=1.95 | Chg30d=+0.00% | Revisions=+17% | GrowthEPS=+18.7% | GrowthRev=+13.5%
[Analyst] Revisions Ratio: +72% (up=14, down=1)